Tirzepatide (10mg)

Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist research peptide that has attracted significant scientific interest for its powerful effects on metabolic regulation. By activating both incretin pathways, Tirzepatide is being extensively studied for its ability to influence appetite control, glucose utilization, insulin secretion, insulin sensitivity, gastric emptying, and overall energy balance.
Clinical research has demonstrated remarkable outcomes in both weight management and glycemic control, with study participants achieving substantial reductions in body weight alongside meaningful improvements in blood glucose levels, HbA1c, insulin resistance, and other key metabolic health markers. Additional investigations have reported favorable effects on cardiovascular risk factors, including blood pressure, lipid profiles, and markers associated with metabolic syndrome.